A Prospective, Randomized, Multicenter Study to Demonstrate the Superiority of the Barricaid to Discectomy for Primary Lumbar Disc Herniation

NCT ID: NCT01283438

Last Updated: 2023-09-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

554 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-12-17

Study Completion Date

2025-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A randomized study to demonstrate the superiority of the Barricaid® when used in conjunction with limited discectomy, compared to limited discectomy alone, with regard to preventing reherniation and the recurrence of pain or dysfunction.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Barricaid is indicated for patients with radiculopathy (with or without back pain), a positive Straight Leg Raise (L45, L5S1) or femoral stretch test (L12, L23, L34), and a posterior or posterolateral herniation at one level between L1 and S1 with radiographic confirmation of neural compression using MRI who are found to have an annular defect (post discectomy) which measures between 4mm and 6mm tall and between 6mm and 10mm wide, have a minimum posterior disc height of 5mm, and have failed at least 6 weeks of conservative treatment including a post-approval amendment with follow-up visits at 7 \& 10 years for eligible subjects.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lumbar Disc Herniation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Barricaid Device

Intervention: Barricaid Device

Group Type EXPERIMENTAL

Barricaid

Intervention Type DEVICE

Annular closure device

Standard of Care

Standard (Limited) Discectomy Only

Group Type ACTIVE_COMPARATOR

Standard of Care

Intervention Type DEVICE

Standard Limited discectomy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Barricaid

Annular closure device

Intervention Type DEVICE

Standard of Care

Standard Limited discectomy

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 21 to 75 years old and skeletally mature (male or female).
* Patients with posterior or posterolateral disc herniations at one level between L1 and S1 with radiographic confirmation of neural compression using Magnetic Resonance Imaging (MRI).
* At least six (6) weeks of failed, conservative treatment prior to surgery
* Oswestry Disability Index (ODI) Questionnaire score of at least 40/100 at baseline.
* Visual Analog Scale (VAS) leg pain (one or both legs) of at least 40/100 at baseline.
* Psychosocially, mentally and physically able to fully comply with the clinical protocol and willing to adhere to follow-up schedule and requirements.

Exclusion Criteria

* Spondylolisthesis Grade II or higher (25% slip or greater).
* Prior surgery at the index lumbar vertebral level.
* Subject has scoliosis of greater than ten (10) degrees (both angular and rotational).
* Any metabolic bone disease.
* Subject has insulin-dependent diabetes mellitus.
* Subject has been diagnosed with active hepatitis, acquired immunodeficiency syndrome (AIDS), or Human immunodeficiency virus (HIV).
* Subject has been diagnosed with rheumatoid arthritis or other autoimmune disease.
* Subject has a known allergy to titanium, polyethylene or polyester materials.
* Any subject that cannot have a baseline MRI taken.
* Subject is pregnant or interested in becoming pregnant in the next three (3) years.
* Subject has active tuberculosis or has had tuberculosis in the past three (3) years.
* Subject is currently involved in another investigational study.
* Any contraindication for MRI or Computed tomography CT scan (e.g. claustrophobia, contrast allergy).
Minimum Eligible Age

21 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Intrinsic Therapeutics

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

LKH Graz

Graz, , Austria

Site Status

Medizinische Universität Innsbruck

Innsbruck, , Austria

Site Status

OLV Aalst

Aalst, , Belgium

Site Status

ZNA Middleheim / AZ Klina

Antwerp, , Belgium

Site Status

AZ Nikolaas

Sint-Niklaas, , Belgium

Site Status

CHRU Lille, Hôpital Roger Salengro

Lille, , France

Site Status

Orthopädische Klinik und Poliklinik - Universitätsmedizin Rostock

Rostock, Mecklenburg-Vorpommern, Germany

Site Status

Neurochirurgische Universitätsklinik Knappschafts-Krankenhaus Bochum-Langendreer

Bochum, North Rhine-Westphalia, Germany

Site Status

Klinikum Augsburg

Augsburg, , Germany

Site Status

Charité - Universitätsmedizin Berlin

Berlin, , Germany

Site Status

Klinikum Deggendorf

Deggendorf, , Germany

Site Status

Universitätsklinikum Düsseldorf

Düsseldorf, , Germany

Site Status

Asklepios Westklinikum Hamburg

Hamburg, , Germany

Site Status

UNI Kiel

Kiel, , Germany

Site Status

St. Bonifatius Hospital GmbH

Lingen, , Germany

Site Status

UMM Mannheim

Mannheim, , Germany

Site Status

SLAZ Amsterdam

Amsterdam, , Netherlands

Site Status

MCH Antoniushove

Leidschendam, , Netherlands

Site Status

MCH Westeinde

The Hague, , Netherlands

Site Status

Isala Klinieken

Zwolle, , Netherlands

Site Status

KSA Aarau

Aarau, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria Belgium France Germany Netherlands Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Thome C, Klassen PD, Bouma GJ, Kursumovic A, Fandino J, Barth M, Arts M, van den Brink W, Bostelmann R, Hegewald A, Heidecke V, Vajkoczy P, Frohlich S, Wolfs J, Assaker R, Van de Kelft E, Kohler HP, Jadik S, Eustacchio S, Hes R, Martens F; Annular Closure RCT Study Group. Annular closure in lumbar microdiscectomy for prevention of reherniation: a randomized clinical trial. Spine J. 2018 Dec;18(12):2278-2287. doi: 10.1016/j.spinee.2018.05.003. Epub 2018 May 3.

Reference Type RESULT
PMID: 29730458 (View on PubMed)

Martens F, Vajkoczy P, Jadik S, Hegewald A, Stieber J, Hes R. Patients at the Highest Risk for Reherniation Following Lumbar Discectomy in a Multicenter Randomized Controlled Trial. JB JS Open Access. 2018 Apr 16;3(2):e0037. doi: 10.2106/JBJS.OA.17.00037. eCollection 2018 Jun 28.

Reference Type RESULT
PMID: 30280130 (View on PubMed)

Klassen PD, Hsu WK, Martens F, Inzana JA, van den Brink WA, Groff MW, Thome C. Post-lumbar discectomy reoperations that are associated with poor clinical and socioeconomic outcomes can be reduced through use of a novel annular closure device: results from a 2-year randomized controlled trial. Clinicoecon Outcomes Res. 2018 Jun 26;10:349-357. doi: 10.2147/CEOR.S164129. eCollection 2018.

Reference Type RESULT
PMID: 29983583 (View on PubMed)

Ament J, Thaci B, Yang Z, Kulubya E, Hsu W, Bouma G, Kim KD. Cost-effectiveness of a Bone-anchored Annular Closure Device Versus Conventional Lumbar Discectomy in Treating Lumbar Disc Herniations. Spine (Phila Pa 1976). 2019 Jan 1;44(1):5-16. doi: 10.1097/BRS.0000000000002746.

Reference Type RESULT
PMID: 29927860 (View on PubMed)

Kursumovic A, Kienzler JC, Bouma GJ, Bostelmann R, Heggeness M, Thome C, Miller LE, Barth M; Annular Closure RCT study group. Morphology and Clinical Relevance of Vertebral Endplate Changes Following Limited Lumbar Discectomy With or Without Bone-anchored Annular Closure. Spine (Phila Pa 1976). 2018 Oct 15;43(20):1386-1394. doi: 10.1097/BRS.0000000000002632.

Reference Type RESULT
PMID: 29538243 (View on PubMed)

Klassen PD, Bernstein DT, Kohler HP, Arts MP, Weiner B, Miller LE, Thome C. Bone-anchored annular closure following lumbar discectomy reduces risk of complications and reoperations within 90 days of discharge. J Pain Res. 2017 Aug 26;10:2047-2055. doi: 10.2147/JPR.S144500. eCollection 2017.

Reference Type RESULT
PMID: 28894388 (View on PubMed)

Thome C, Kursumovic A, Klassen PD, Bouma GJ, Bostelmann R, Martens F, Barth M, Arts M, Miller LE, Vajkoczy P, Hes R, Eustacchio S, Nanda D, Kohler HP, Brenke C, Fluh C, Van de Kelft E, Assaker R, Kienzler JC, Fandino J; Annular Closure RCT Study Group. Effectiveness of an Annular Closure Device to Prevent Recurrent Lumbar Disc Herniation: A Secondary Analysis With 5 Years of Follow-up. JAMA Netw Open. 2021 Dec 1;4(12):e2136809. doi: 10.1001/jamanetworkopen.2021.36809.

Reference Type DERIVED
PMID: 34882183 (View on PubMed)

Kienzler JC, Fandino J, Van de Kelft E, Eustacchio S, Bouma GJ; Barricaid(R) Annular Closure RCT Study Group. Risk factors for early reherniation after lumbar discectomy with or without annular closure: results of a multicenter randomized controlled study. Acta Neurochir (Wien). 2021 Jan;163(1):259-268. doi: 10.1007/s00701-020-04505-4. Epub 2020 Oct 21.

Reference Type DERIVED
PMID: 33085021 (View on PubMed)

van den Brink W, Fluh C, Miller LE, Klassen PD, Bostelmann R. Lumbar disc reherniation prevention with a bone-anchored annular closure device: 1-year results of a randomized trial. Medicine (Baltimore). 2019 Nov;98(44):e17760. doi: 10.1097/MD.0000000000017760.

Reference Type DERIVED
PMID: 31689835 (View on PubMed)

Kienzler JC, Klassen PD, Miller LE, Assaker R, Heidecke V, Frohlich S, Thome C; Annular Closure RCT Study Group. Three-year results from a randomized trial of lumbar discectomy with annulus fibrosus occlusion in patients at high risk for reherniation. Acta Neurochir (Wien). 2019 Jul;161(7):1389-1396. doi: 10.1007/s00701-019-03948-8. Epub 2019 May 15.

Reference Type DERIVED
PMID: 31089894 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EUBARD-CP-011

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PRESTIGE® Cervical Disc Study
NCT00642876 COMPLETED NA